Finance

Lists
002773:SHE
Chengdu Kanghong Pharma Grp Co Ltd
CN¥ १९.४४
-१.९२%
(-०.३८) 1D
अक्टोबर १६, १५:०४:०९ GMT+८  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002773...
Open
CN¥ २०.३४
High
CN¥ २०.३४
Low
CN¥ १९.३०
Mkt. cap
१८.६१ अरब
Avg. vol.
७२.९७ लाख
Volume
६५.८६ लाख
Dividend
३.६०%
Quarterly dividend
CN¥ ०.१७
Ex-dividend date
२०२६ जुन ९
P/E ratio
१८.००
52-wk high
CN¥ ३६.१०
52-wk low
CN¥ १८.६२
EPS
CN¥ १.०८
Shares outstanding
९२.१३ करोड
No. of employees
४ हजार
Open
CN¥ २०.३४
High
CN¥ २०.३४
Low
CN¥ १९.३०
Mkt. cap
१८.६१ अरब
Avg. vol.
७२.९७ लाख
Volume
६५.८६ लाख
Dividend
३.६०%
Quarterly dividend
CN¥ ०.१७
Ex-dividend date
२०२६ जुन ९
P/E ratio
१८.००
52-wk high
CN¥ ३६.१०
52-wk low
CN¥ १८.६२
EPS
CN¥ १.०८
Shares outstanding
९२.१३ करोड
No. of employees
४ हजार
News stories
From web sources and news partners
Profile
Chengdu Kanghong Pharmaceutical Group Co., Ltd. is a publicly traded pharmaceutical company based in the province of Sichuan, China. It was founded in 1996 and researches, develops, manufactures, and distributes medicines for ophthalmic, central nervous, digestive and endocrine systems. The company is listed on the Shenzhen stock exchange with a market capitalization at around $6 billion. As of May 2021, the company had 18 drugs on the market including Lumitin. Additional products include Songling xuemaikang capsules, Keluoxin capsules, Xinluona, Bolexin and Bosiqing, Yitaning, Shugan Jieyu, Danshu, and Yiqing. Kanghong also currently has 13 subsidiaries in China, Israel, and the United States. Wikipedia
About Chengdu Kanghong Pharma Grp Co Ltd
CEO-
Employees४.४७ हजार
Founded१९९६ अक्टोबर ३
Headquarters-
Sector-
Websitecnkh.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.१७ अरब
९६.१३ करोड
१.०५ अरब
१.१३ अरब
Cost of goods sold
१०.३२ करोड
११.६९ करोड
११.८७ करोड
१३.२० करोड
Cost of revenue
१०.३२ करोड
११.६९ करोड
११.८७ करोड
१३.२० करोड
Research and development expenses
११.९५ करोड
१९.८९ करोड
८.६८ करोड
१३.८६ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५९.५३ करोड
५२.१८ करोड
४७.८९ करोड
५५.४५ करोड
Operating expense
६९.७० करोड
७६.४४ करोड
५८.२८ करोड
७१.७८ करोड
Total operating expenses
८०.०२ करोड
८८.१३ करोड
७०.१५ करोड
८४.९८ करोड
Operating income
३७.०० करोड
८.०० करोड
३४.५० करोड
२८.२९ करोड
Other non operating income
-१.९५ करोड
१.९३ करोड
-१०.४३ लाख
-१५.३८ लाख
EBT including unusual items
३५.६० करोड
१४.७७ करोड
३५.८५ करोड
३०.१९ करोड
EBT excluding unusual items
३६.४७ करोड
१३.६० करोड
३५.६४ करोड
३०.६३ करोड
Income tax expense
५.६७ करोड
२.३३ करोड
५.५३ करोड
५.०१ करोड
Effective tax rate
१५.९४%
१५.७७%
१५.४३%
१६.६१%
Other operating expenses
-१.७८ करोड
४.३९ करोड
१.६६ करोड
२.३२ करोड
Net income
३०.३२ करोड
१३.०१ करोड
३०.७५ करोड
२५.७३ करोड
Net profit margin
२५.९१%
१३.५३%
२९.३८%
२२.७१%
Earnings per share
-
-
-
-
Interest and investment income
१.४२ करोड
३.६९ करोड
१.२६ करोड
२.४९ करोड
Interest expense
-
-
-
-
Net interest expenses
१.४२ करोड
३.६९ करोड
१.२६ करोड
२.४९ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
४२.७३ करोड
१३.९१ करोड
४०.४१ करोड
३४.५१ करोड
Gain or loss from assets sale
३.४७ हजार
-९.७८ हजार
-
६१.०६ हजार
AI content may include mistakes. Learn more
Google एपहरू